{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:08:55Z","timestamp":1773446935089,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Major Special Science and Technology Project of Anhui Province","award":["201903a07020030"],"award-info":[{"award-number":["201903a07020030"]}]},{"name":"the Major Special Science and Technology Project of Anhui Province","award":["201903a07020030"],"award-info":[{"award-number":["201903a07020030"]}]},{"name":"the Major Special Science and Technology Project of Anhui Province","award":["201903a07020030"],"award-info":[{"award-number":["201903a07020030"]}]},{"name":"the Major Special Science and Technology Project of Anhui Province","award":["201903a07020030"],"award-info":[{"award-number":["201903a07020030"]}]},{"name":"the Major Special Science and Technology Project of Anhui Province","award":["201903a07020030"],"award-info":[{"award-number":["201903a07020030"]}]},{"name":"the Natural Science Foundation of Anhui Province","award":["2208085MH217"],"award-info":[{"award-number":["2208085MH217"]}]},{"name":"the Natural Science Foundation of Anhui Province","award":["2208085MH217"],"award-info":[{"award-number":["2208085MH217"]}]},{"name":"the Natural Science Foundation of Anhui Province","award":["2208085MH217"],"award-info":[{"award-number":["2208085MH217"]}]},{"name":"the Natural Science Foundation of Anhui Province","award":["2208085MH217"],"award-info":[{"award-number":["2208085MH217"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00277-024-05790-0","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T02:01:36Z","timestamp":1715306496000},"page":"2551-2556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["DNT cells mediate resistance to CAR-T cells therapy in a pediatric patient with relapsed and refractory B-ALL"],"prefix":"10.1007","volume":"103","author":[{"given":"Ruotong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianshan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caixian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"key":"5790_CR1","doi-asserted-by":"crossref","unstructured":"Bulliard Y, Andersson BS, Baysal MA, Damiano J, Tsimberidou AM (2023) Reprogramming T cell differentiation and exhaustion in CAR-T cells therapy. Journal of Hematology & Oncology 16(1):108. doi:https:\/\/doi.org0.1186\/s13045-023-01504-7","DOI":"10.1186\/s13045-023-01504-7"},{"key":"5790_CR2","doi-asserted-by":"publisher","first-page":"103941","DOI":"10.1016\/j.ebiom.2022.103941","volume":"77","author":"D Gumber","year":"2022","unstructured":"Gumber D, Wang LD (2022) Improving CAR-T immunotherapy: overcoming the challenges of T cell exhaustion. Ebiomedicine 77:103941. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103941","journal-title":"Ebiomedicine"},{"issue":"15","key":"5790_CR3","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1182\/blood-2018-11-883710","volume":"133","author":"KA Hay","year":"2019","unstructured":"Hay KA, Gauthier J, Hirayama AV, Voutsinas JM, Wu Q, Li D, Gooley TA, Cherian S, Chen X, Pender BS, Hawkins RM, Vakil A, Steinmetz RN, Schoch G, Chapuis AG, Till BG, Kiem H-P, Ramos JD, Shadman M, Cassaday RD, Acharya UH, Riddell SR, Maloney DG, Turtle CJ (2019) Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy. Blood 133(15):1652\u20131663. https:\/\/doi.org\/10.1182\/blood-2018-11-883710","journal-title":"Blood"},{"issue":"586","key":"5790_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1126\/scitranslmed.abb5191","volume":"13","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liu G, Wang J, Zheng Z-Y, Jia L, Rui W, Huang D, Zhou Z-X, Zhou L, Wu X, Lin S, Zhao X, Lin X (2021) Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors. Sci Transl Med 13(586):51\u201391. https:\/\/doi.org\/10.1126\/scitranslmed.abb5191","journal-title":"Sci Transl Med"},{"issue":"8","key":"5790_CR5","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/s41591-021-01436-0","volume":"27","author":"JY Spiegel","year":"2021","unstructured":"Spiegel JY, Patel S, Muffly L, Hossain NM, Oak J, Baird JH, Frank MJ, Shiraz P, Sahaf B, Craig J, Iglesias M, Younes S, Natkunam Y, Ozawa MG, Yang E, Tamaresis J, Chinnasamy H, Ehlinger Z, Reynolds W, Lynn R, Rotiroti MC, Gkitsas N, Arai S, Johnston L, Lowsky R, Majzner RG, Meyer E, Negrin RS, Rezvani AR, Sidana S, Shizuru J, Weng W-K, Mullins C, Jacob A, Kirsch I, Bazzano M, Zhou J, Mackay S, Bornheimer SJ, Schultz L, Ramakrishna S, Davis KL, Kong KA, Shah NN, Qin H, Fry T, Feldman S, Mackall CL, Miklos DB (2021) CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med 27(8):1419\u20131431. https:\/\/doi.org\/10.1038\/s41591-021-01436-0","journal-title":"Nat Med"},{"issue":"20","key":"5790_CR6","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.3390\/cancers13205039","volume":"13","author":"H Kang","year":"2022","unstructured":"Kang H (2022) Enhancing therapeutic efficacy of double negative T cells against Acute myeloid leukemia using Idelalisib. Cancers 13(20):5039. https:\/\/doi.org\/10.3390\/cancers13205039","journal-title":"Cancers"},{"issue":"2","key":"5790_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/1078-0432.Ccr-17-2228","volume":"24","author":"J Lee","year":"2018","unstructured":"Lee J, Minden MD, Chen WC, Streck E, Chen B, Kang H, Arruda A, Ly D, Der SD, Kang S, Achita P, D\u2019Souza C, Li Y, Childs RW, Dick JE, Zhang L (2018) Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute myeloid leukemia and its underlying mechanisms. Clin Cancer Res 24(2):370\u2013382. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-2228","journal-title":"Clin Cancer Res"},{"key":"5790_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0507-2","volume":"7","author":"J Yao","year":"2019","unstructured":"Yao J, Ly D, Dervovic D, Fang L, Lee JB, Kang H, Wang Y-H, Nhu-An P, Pan H, Tsao M-S, Zhang L (2019) Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15. J Immunother Cancer 7:1\u201314. https:\/\/doi.org\/10.1186\/s40425-019-0507-2","journal-title":"J Immunother Cancer"},{"issue":"1","key":"5790_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41571-022-00704-3","volume":"20","author":"CL Flugel","year":"2023","unstructured":"Flugel CL, Majzner RG, Krenciute G, Dotti G, Riddell SR, Wagner DL, Abou-el-Enein M (2023) Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours. Nat Reviews Clin Oncol 20(1):49\u201362. https:\/\/doi.org\/10.1038\/s41571-022-00704-3","journal-title":"Nat Reviews Clin Oncol"},{"key":"5790_CR10","doi-asserted-by":"publisher","unstructured":"Fang KK-L, Lee J, Khatri I, Na Y, Zhang L (2023) Targeting T-cell malignancies using allogeneic double-negative CD4-CAR-T cellss. J Immunother Cancer 11(9). https:\/\/doi.org\/10.1136\/jitc-2023-007277","DOI":"10.1136\/jitc-2023-007277"},{"issue":"4","key":"5790_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hon.2541","volume":"36","author":"S Shen","year":"2018","unstructured":"Shen S, Cai J, Chen J, Xue H, Pan C, Gao Y, Tang Y, Wang J, Li B, Wang X, Chen J, Gu L, Tang J (2018) Long-term results of the risk-stratified treatment of childhood acute lymphoblastic leukemia in China. Hematol Oncol 36(4):679\u2013688. https:\/\/doi.org\/10.1002\/hon.2541","journal-title":"Hematol Oncol"},{"issue":"5","key":"5790_CR12","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1172\/jci125423","volume":"129","author":"OC Finney","year":"2019","unstructured":"Finney OC, Brakke H, Rawlings-Rhea S, Hicks R, Doolittle D, Lopez M, Futrell B, Orentas RJ, Li D, Gardner R, Jensen MC (2019) CD19 CAR T cell product and disease attributes predict leukemia remission durability. J Clin Invest 129(5):2123\u20132132. https:\/\/doi.org\/10.1172\/jci125423","journal-title":"J Clin Invest"},{"issue":"9","key":"5790_CR13","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/leu.2011.99","volume":"25","author":"S Merims","year":"2011","unstructured":"Merims S, Li X, Joe B, Dokouhaki P, Han M, Childs RW, Wang ZY, Gupta V, Minden MD, Zhang L (2011) Anti-leukemia effect of Ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy. Leukemia 25(9):1415\u20131422. https:\/\/doi.org\/10.1038\/leu.2011.99","journal-title":"Leukemia"},{"issue":"11","key":"5790_CR14","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.4049\/jimmunol.1601991","volume":"198","author":"VR Chowdhary","year":"2017","unstructured":"Chowdhary VR, Krogman A, Tilahun AY, Alexander MP, David CS, Rajagopalan G (2017) Concomitant disruption of CD4 and CD8 genes facilitates the development of double negative \u03b1\u03b2 TCR\u2009+\u2009peripheral T cells that respond robustly to Staphylococcal Superantigen. J Immunol 198(11):4413\u20134424. https:\/\/doi.org\/10.4049\/jimmunol.1601991","journal-title":"J Immunol"},{"issue":"2","key":"5790_CR15","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1084\/jem.20192191","volume":"218","author":"ME Maccari","year":"2021","unstructured":"Maccari ME, Fuchs S, Kury P, Andrieux G, Volkl S, Bengsch B, Lorenz MR, Heeg M, Rohr J, Jagle S, Castro CN, Gross M, Warthorst U, Koenig C, Fuchs I, Speckmann C, Thalhammer J, Kapp FG, Seidel MG, Duckers G, Schoenberger S, Schuetz C, Fuhrer M, Kobbe R, Holzinger D, Klemann C, Smisek P, Owens S, Horneff G, Kolb R, Naumann-Bartsch N, Miano M, Staniek J, Rizzi M, Kalina T, Schneider P, Erxleben A, Backofen R, Ekici A, Niemeyer CM, Warnatz K, Grimbacher B, Eibel H, Mackensen A, Frei AP, Schwarz K, Boerries M, Ehl S, Rensing-Ehl A (2021) A distinct CD38\u2009+\u2009CD45RA\u2009+\u2009population of CD4+, CD8+, and double-negative T cells is controlled by FAS. J Exp Med 218(2):2019\u20132191. https:\/\/doi.org\/10.1084\/jem.20192191","journal-title":"J Exp Med"},{"issue":"2","key":"5790_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2174\/1573396318666220901165247","volume":"19","author":"V Graiqevci-Uka","year":"2023","unstructured":"Graiqevci-Uka V, Behluli E, Spahiu L, Liehr T, Temaj G (2023) Targeted treatment and immunotherapy in high-risk and Relapsed\/ refractory Pediatric Acute Lymphoblastic Leukemia. Curr Pediatr Reviews 19(2):150\u2013156. https:\/\/doi.org\/10.2174\/1573396318666220901165247","journal-title":"Curr Pediatr Reviews"},{"key":"5790_CR17","doi-asserted-by":"publisher","first-page":"1077419","DOI":"10.3389\/fgene.2022.1077419","volume":"13","author":"R Zhu","year":"2023","unstructured":"Zhu R, Yan Q, Wang Y, Wang K (2023) Biological characteristics of \u03b3\u03b4T cells and application in tumor immunotherapy. Front Genet 13:1077419. https:\/\/doi.org\/10.3389\/fgene.2022.1077419","journal-title":"Front Genet"},{"issue":"4","key":"5790_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/imm.13441","volume":"165","author":"T Velikkakam","year":"2022","unstructured":"Velikkakam T, Gollob KJ, Dutra WO (2022) Double-negative T cells: setting the stage for disease control or progression. Immunology 165(4):371\u2013385. https:\/\/doi.org\/10.1111\/imm.13441","journal-title":"Immunology"},{"issue":"1","key":"5790_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12672-023-00770-8","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Zhu R, Wang Y, Wang K (2023) Classification and function of \u03b3\u03b4T cells and its research progress in anti-glioblastoma. Discover Oncol 14(1):150. https:\/\/doi.org\/10.1007\/s12672-023-00770-8","journal-title":"Discover Oncol"},{"issue":"7","key":"5790_CR20","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41568-019-0153-5","volume":"19","author":"B Silva-Santos","year":"2019","unstructured":"Silva-Santos B, Mensurado S, Coffelt SB (2019) \u03b3\u03b4 T cells: pleiotropic immune effectors with therapeutic potential in cancer. Nat Rev Cancer 19(7):392\u2013404. https:\/\/doi.org\/10.1038\/s41568-019-0153-5","journal-title":"Nat Rev Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05790-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05790-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05790-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T16:06:46Z","timestamp":1720109206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05790-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["5790"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05790-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,10]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was reviewed and approved by the Institutional Review Board Institutional at the Second Affiliated Hospital of Anhui Medical University (SL-YX:2015-06-01). A written informed consent was obtained from the patient for the publication of the details of the medical case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors signed informed consent for publishing the data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}